ArticleJournal of dentistry (Shiraz, Iran)2026
Investigating the Relationship Human Parvovirus B19 Infection in Benign and Malignant Salivary Gland Tumors.
Article in Journal of dentistry (Shiraz, Iran), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Parvovirus B19 is a common virus that can affect everyone, especially immunocompromised patients. The virus is present in various leukemias and solid tumors, and several B19-related diseases including autoimmune disorders, hepatitis, vasculitis, acute and chronic inflammatory diseases, and some thyroid cancers have been described. Purpose: This investigation aimed to quantify the frequency of human Parvovirus-B19 infection in salivary gland tumors, both benign and malignant. Materials and Method: In this cross-sectional study, 71 formalin-fixed, paraffin-embedded tissue specimens associated with benign and malignant salivary gland tumors, along with tissues from 30 normal salivary glands from the maxillofacial pathology laboratory of Shiraz Dental School, Chamran, and Rajai teaching hospitals (the main two major referral centers), were examined using nested-PCR to determine if B19 DNA was present. All data, including age, sex, location, and the presence of the virus, were considered, presented in tables, and statistically analyzed. The prevalence of B19 was compared to the normal salivary gland group. Results: B19 DNA was identified in 11 specimens (15.5%) out of the 71 available specimens from the patient group. None of the specimens from the normal salivary gland group tested positive for B19 DNA. Consequently, the prevalence of B19 in the patient group was significantly higher than that in the normal salivary gland group ( Conclusion: Our results indicated a relationship between the presence of B19 parvovirus in the patient group compared to that in the control groups. Based on our study's findings, it can be assumed that B19 virus is likely to be presenting in both benign and malignant salivary gland tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.